|
|
 |
|
 |
|
|
|
|
Title:
|
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men - IRB #06-36B
|
|
Treatments:
|
-- none --
|
|
Disease Site:
|
Cancer control
|
|
Disease SubSite:
|
Tissue repository
|
|
Drug Provided:
|
-- none --
|
|
Comments:
|
SWOG (Automatic Specimen Reimbursement): Specimen Tracking System)
|
|
Eligibility:
|
Pts must have newly diagnosed, primary, histologically confirmed Stage I, II or IIIB (T4 or N3, excluding patients w/ malignant pleural effusion) NSCLC; Pts w/effusion are eligible if: a)fluid tapped is benign cytology and all physicians concur that it is from a benign etiology, b) fluid present after mediastinoscopy or thoracotomy, but not before, c) fluid deemed too small to tap under CT or U/S guidance; May be registered concurrently to a therapeutic study but not required to be on a therapeutic study; Must have tumor block/slides available and willing to provide tissue and blood sample for testing; Must have specific tissue specimens available as outlined in Section 4.2; Able and willing to complete the Lung Cancer Epidemiology Questionnaire and able to read and understand English; Must be identified and registered w/in 120 days of diagnosis; Must be willing to provide smoking history; Pts must not have diagnosis by cytology alone; Pts must not have malignant pleural effusion; Pts must not have other prior malignancy except for treated basal cell (or squamous cell) skin ca or in situ cervical ca; Pts must not have prior systemic chemotherapy or RT for cancer; Pts must not have pericardial effusions. NOTE: Pts registered concurrently to therapeutic trials must have blood and tissue obtained PRIOR to administration of ANY therapeutic agent(s)
|
|
Participating Sites:
|
Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center
|
|
|
|
|
 |
|
 |
|
|
|